Active Pharmaceutical Ingredients
- Industrial Coatings
- Dyes and Pigments
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
- Analytical Chemistry
- Cosmetic Ingredient
- Pharmaceutical Intermediates
Recently, the State Medical Products Administration approved the marketing
of the Class 1 innovative drug Torudiven Lafaxine hydrochloride sustained-release tablets (trade name: Ruoxinlin) declared by Shandong Luye Pharmaceutical Co.
The drug is an innovative drug independently developed by China with independent intellectual property rights, which is suitable for the treatment
The antidepressant effect of torludivenlafaxine hydrochloride may be related to
the enhancement of 5-HT, NE effects of the central nervous system by inhibiting the reuptake of serotonin (5-HT), norepinephrine (NE).
The launch of the drug provides more treatment options
for patients with depression.
Source/ NMPA website